Sistema de Salut de Catalunya
[Mora T] Research Institute for Evaluation and Public Policies (IRAPP), Universitat Internacional de Catalunya (UIC), Barcelona, Spain. [Puig-Junoy J] Barcelona School of Management (UPF-BSM), Universitat Pompeu Fabra, Barcelona, Spain. [Jacobs R] Centre for Health Economics (CHE), University of York, York, United Kingdom. [Cid J] Grup de Recerca en Salut Mental i Addiccions Institut d’Assistència Sanitària (IAS), Girona, Spain. Institut d’Investigació Biomèdica de Girona (IDIBGI), Girona, Spain
Institut d'Assistència Sanitària
2023-05-02T10:20:05Z
2023-05-02T10:20:05Z
2023-04-22
TDAH; Cost de la malaltia; Població no adulta
TDAH; Costo de la enfermedad; Población no adulta
ADHD; Cost-of-illness; Non-adult population
Attention-Deficit/Hyperactivity Disorder (ADHD) is young children's most common mental health disorder. We aim to provide causal estimates of the differential costs for the non-adult population with ADHD. We used longitudinal administrative data covering the non-adult population over five years and different healthcare providers (general practitioners, hospitalisations and emergency departments, visits to mental healthcare centres-day-care or hospitals) of 1,101,215 individuals in Catalonia (Spain). We also include the consumption of pharmaceuticals and cognitive therapies. We instrumented ADHD diagnosis by the probability of being diagnosed by the most visited healthcare provider based on individual monthly visits to the provider in which this visit was related to ADHD and the density of professionals in the different mental health providers. After using matching procedures to include a proper control group, we estimated two-part and finite mixture models. Our results indicate that ADHD children and adolescents displayed 610€ higher annual health direct costs compared to not diagnosed counterparts. We provide average costs disentangling the sample by age boundaries, gender, and comorbidities to offer values for cost-effective analyses and incremental costs after diagnosis, which is around 400€. A significant differential annual direct health cost for the non-adult population with ADHD is determined, which will be helpful for cost-effectiveness analysis and complete cost-of-illness studies.
Toni Mora gratefully acknowledges the financial support from the ECO2017-83771-C3-3-R (MINECO/AEI/FEDER, UE) and its continuation PID2021-124067OB-C21
Article
English
Trastorn per dèficit d'atenció amb hiperactivitat; Infants; Assistència sanitària - Cost; PSYCHIATRY AND PSYCHOLOGY::Mental Disorders::Neurodevelopmental Disorders::Attention Deficit and Disruptive Behavior Disorders::Attention Deficit Disorder with Hyperactivity; HEALTH CARE::Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost of Illness; NAMED GROUPS::Persons::Age Groups::Child; PSIQUIATRÍA Y PSICOLOGÍA::trastornos mentales::trastornos del desarrollo neurológico::trastornos conductuales disruptivos y déficit de atención::trastornos de déficit de atención con hiperactividad; ATENCIÓN DE SALUD::economía y organizaciones para la atención de la salud::economía::costes y análisis de costes::coste de las enfermedades; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño
BMC
Health Economics Review;13
https://doi.org/10.1186/s13561-023-00437-8
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
